Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 4 Exercise or conversion Chief Financial Officer acquired 120,000 shares (option exercise)
  2. 4 Open-market sale SVP, Product Development & CTO sold 43,832 shares at $50.08 ($2,195,107)
  3. 4 Exercise or conversion President and CEO acquired 45,000 shares (option exercise)
  4. 4 Open-market sale President and CEO sold 15,000 shares at an average $43.85 ($657,698)
  5. 4 Grant or award SVP, General Counsel acquired 337 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale SVP, General Counsel sold 5,000 shares at an average $47.54 ($237,698)
  11. 4 Open-market sale Chief Financial Officer sold 7,500 shares at an average $46.35 ($347,650)
  12. 4 Open-market sale President and CEO sold 15,000 shares at an average $46.73 ($700,927)
  13. 4 Open-market sale Chief Medical Officer sold 20,414 shares at an average $60.13 ($1,227,412)
  14. 4 Open-market sale President and CEO sold 20,000 shares at an average $60.40 ($1,208,087)
  15. 4 Exercise or conversion Chief Scientific Officer acquired 1,500 shares (option exercise)
  16. 4 Open-market sale Director sold 12,784 shares at $65.00 ($830,960)
  17. 4 Open-market sale Director sold 20,507 shares at an average $65.03 ($1,333,519)
  18. 4 Open-market sale President and CEO sold 20,000 shares at an average $64.17 ($1,283,355)
  19. 4 Open-market sale President and CEO sold 15,000 shares at an average $61.44 ($921,660)
  20. 4 Open-market sale Director sold 33,292 shares at an average $60.44 ($2,012,209)

Page 13 of 22 · 435 filings